BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pavlidou A, Dalamaga M, Kroupis C, Konstantoudakis G, Belimezi M, Athanasas G, Dimas K. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J Gastroenterol 2011; 17(12): 1614-1621 [PMID: 21472129 DOI: 10.3748/wjg.v17.i12.1614]
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1614.htm
Number Citing Articles
1
Maria Dalamaga. Clinical metabolomics: useful insights, perspectives and challengesMetabolism Open 2024; : 100290 doi: 10.1016/j.metop.2024.100290
2
Kalliopi Ch. Athanasoula, Helen Gogas, Katerina Polonifi, Aristeidis G. Vaiopoulos, Aristidis Polyzos, Marina Mantzourani. Survivin beyond physiology: Orchestration of multistep carcinogenesis and therapeutic potentialsCancer Letters 2014; 347(2): 175 doi: 10.1016/j.canlet.2014.02.014
3
Yibing Fan, Juan Chen. Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysisBioengineered 2017; 8(5): 511 doi: 10.1080/21655979.2016.1252879
4
Irene Karampela, Natalia G. Vallianou, Dimitrios Tsilingiris, Gerasimos Socrates Christodoulatos, Sotiria Psallida, Dimitris Kounatidis, Theodora Stratigou, Ioanna Marinou, Evaggelos Vogiatzakis, Maria Dalamaga. Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic ImplicationsBiomolecules 2024; 14(3): 291 doi: 10.3390/biom14030291
5
Ioannis G. Lempesis, Junli Liu, Maria Dalamaga. The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesityMetabolism Open 2022; 16: 100220 doi: 10.1016/j.metop.2022.100220
6
Juanjuan Li, Mei Yue, Xiaodong Shi, Shunqiao Feng, Ruihong Tang, Xia Zhang, Rong Liu, Ziqin Liu, Tianyou Wang. EVALUATION OF ANTI-CANCER ACTIVITY OF SURVIVIN siRNA DELIVERED BY FOLATE RECEPTOR-TARGETED POLYETHYLENE-GLYCOL LIPOSOMES IN K562-BEARING XENOGRAFT MICEBiomedical Engineering: Applications, Basis and Communications 2014; 26(02): 1450026 doi: 10.4015/S1016237214500264
7
Y de Jong, J G van Oosterwijk, A B Kruisselbrink, I H Briaire-de Bruijn, G Agrogiannis, Z Baranski, A H G Cleven, A-M Cleton-Jansen, B van de Water, E H J Danen, J V M G Bovée. Targeting survivin as a potential new treatment for chondrosarcoma of boneOncogenesis 2016; 5(5): e222 doi: 10.1038/oncsis.2016.33
8
Jose Prados, Consolacion Melguizo, Hector Roldan, Pablo J. Alvarez, Raul Ortiz, Jose L. Arias, Antonia Aranega. RNA Interference in the Treatment of Colon CancerBioDrugs 2013; 27(4): 317 doi: 10.1007/s40259-013-0019-4
9
Majid Zaki Dizaji, Seyed H Ghaffari, Elham Hosseini, Nasrin Alizadeh, Shahrbano Rostami, Majid Momeny, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Survivin isoform expression in arsenic trioxide‐treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin‐2αAsia-Pacific Journal of Clinical Oncology 2017; 13(2) doi: 10.1111/ajco.12589
10
Mario Alejandro Lorenzetti, María Jimena Mosna, Elena Noemí De Matteo, Mercedes García Lombardi, Sandra Lorena Colli, María Victoria Preciado. Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profileExperimental and Molecular Pathology 2019; 108: 24 doi: 10.1016/j.yexmp.2019.03.005
11
Efsun Eren-Keleş, Halil Gürhan Karabulut, Hasan Fatih Çakmaklı, Başak Adaklı, Serdar Kenan Köse, Handan Uğur-Dinçaslan, Gülsan Yavuz, Mehmet Ertem, Ajlan Tükün. Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic LeukemiaGenetic Testing and Molecular Biomarkers 2018; 22(12): 680 doi: 10.1089/gtmb.2018.0152
12
Natalia G. Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, Fotis Panagopoulos, Gerasimos Socrates Christodoulatos, Angelos Evangelopoulos, Irene Karampela, Maria Dalamaga. The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future PerspectivesInternational Journal of Molecular Sciences 2023; 24(7): 6755 doi: 10.3390/ijms24076755
13
Rosalia de Necochea-Campion, Chien-Shing Chen, Saied Mirshahidi, Frank D. Howard, Nathan R. Wall. Clinico-pathologic relevance of Survivin splice variant expression in cancerCancer Letters 2013; 339(2): 167 doi: 10.1016/j.canlet.2013.06.007
14
Marieke A. de Graaff, Shruti Malu, Irma Guardiola, Alwine B. Kruisselbrink, Yvonne de Jong, Willem E. Corver, H. Gelderblom, Patrick Hwu, Torsten O. Nielsen, Alexander J. Lazar, Neeta Somaiah, Judith V.M.G. Bovée. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor GrowthTranslational Oncology 2017; 10(4): 546 doi: 10.1016/j.tranon.2017.05.007
15
Rupa Mishra, Vinayak Palve, Sadhana Kannan, Sagar Pawar, Tanuja Teni. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancersOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2015; 120(4): 497 doi: 10.1016/j.oooo.2015.06.027
16
Ioannis G. Lempesis, Dimitrios Tsilingiris, Junli Liu, Maria Dalamaga. Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studiesMetabolism Open 2022; 15: 100208 doi: 10.1016/j.metop.2022.100208
17
Dimitrios Tsilingiris, Natalia G. Vallianou, Irene Karampela, Gerasimos Socrates Christodoulatos, Georgios Papavasileiou, Dimitra Petropoulou, Faidon Magkos, Maria Dalamaga. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and ChallengesInternational Journal of Molecular Sciences 2023; 24(13): 10458 doi: 10.3390/ijms241310458
18
K. Miura, W. Fujibuchi, M. Unno. Splice isoforms as therapeutic targets for colorectal cancerCarcinogenesis 2012; 33(12): 2311 doi: 10.1093/carcin/bgs347
19
Chaohui Xiong, Haipeng Liu, Zexin Chen, Yunxian Yu, Chaozhao Liang. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysisEuropean Journal of Internal Medicine 2016; 33: 102 doi: 10.1016/j.ejim.2016.06.009
20
Javier Gaytan-Cervantes, Carolina Gonzalez-Torres, Vilma Maldonado, Cecilia Zampedri, Gisela Ceballos-Cancino, Jorge Melendez-Zajgla. Protein Sam68 regulates the alternative splicing of survivin DEx3Journal of Biological Chemistry 2017; 292(33): 13745 doi: 10.1074/jbc.M117.800318
21
Maria Dalamaga, Dimitrios Kounatidis, Dimitrios Tsilingiris, Natalia G. Vallianou, Irene Karampela, Sotiria Psallida, Athanasios G. Papavassiliou. The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and ControversiesInternational Journal of Molecular Sciences 2024; 25(1): 675 doi: 10.3390/ijms25010675
22
Anastasia Pavlidou, Christos Kroupis, Nikolaos Goutas, Maria Dalamaga, Kleanthi Dimas. Validation of a Real-Time Quantitative Polymerase Chain Reaction Method for the Quantification of 3 Survivin Transcripts and Evaluation in Breast Cancer TissuesClinical Breast Cancer 2014; 14(2): 122 doi: 10.1016/j.clbc.2013.10.012
23
Georgios Papavasileiou, Dimitrios Tsilingiris, Nikolaos Spyrou, Natalia G. Vallianou, Irene Karampela, Faidon Magkos, Maria Dalamaga. Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challengesSeminars in Cancer Biology 2023; 91: 70 doi: 10.1016/j.semcancer.2023.03.002
24
Ishrat Rasool, Dil Afroze, Khursheed Alam Wani, Syed Basina Yasin, Adfar Yousuf, Showket Hussain, Shweta Dubey. Altered expression of survivin and its splice variants ∆Ex3 and 2B contributes to disease development in breast cancerMeta Gene 2019; 19: 168 doi: 10.1016/j.mgene.2018.11.011
25
Quan-Xing Ge, Yu-Yuan Li, Yu-Qiang Nie, Wen-Ge Zuo, Yan-Lei Du. Expression of survivin and its four splice variants in colorectal cancer and its clinical significancesMedical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0535-6
26
Solmaz Moniri Javadhesari, Javad Gharechahi, Mohammad Ali Hosseinpour Feizi, Vahid Montazeri, Monireh Halimi. Transcriptional Expression Analysis of Survivin Splice Variants Reveals Differential Expression of Survivin-3α in Breast CancerGenetic Testing and Molecular Biomarkers 2013; 17(4): 314 doi: 10.1089/gtmb.2012.0411